Kidney Channel Protein Drives Aging and Fibrosis After Acute Kidney Injury
Scientists identify Pannexin1 as a calcium leak channel in the ER that triggers cellular senescence and kidney scarring after acute injury.
Summary
Researchers at Southern Medical University discovered that Pannexin1 (Panx1), a channel protein found in kidney tubule cells, plays an unexpected role inside the endoplasmic reticulum (ER) — leaking calcium onto mitochondria, causing overload, dysfunction, and pro-senescence signals. Using mouse models of acute kidney injury (AKI) and human kidney tissue, they showed that elevated Panx1 drives tubular cell senescence and subsequent kidney fibrosis, the hallmarks of the AKI-to-chronic kidney disease (CKD) transition. Deleting the Panx1 gene in mice significantly reduced both senescence and fibrosis. These findings position ER-resident Panx1 as a novel and potentially druggable driver of kidney disease progression.
Detailed Summary
Acute kidney injury affects roughly 20–31% of hospitalized patients, and survivors face substantially elevated risk of progressing to chronic kidney disease — a condition burdening over 13% of the global population. The molecular mechanisms driving this AKI-to-CKD transition, particularly the role of cellular senescence in tubular epithelial cells (TECs), have remained incompletely understood. This study provides a mechanistic explanation centered on a noncanonical function of the channel protein Pannexin1 (Panx1).
While Panx1 is classically studied as a plasma membrane ATP-release channel, the authors demonstrate that a pool of Panx1 resides within the endoplasmic reticulum (ER), where it functions as a calcium (Ca²⁺) leak channel. This ER-resident Panx1 was found to operate specifically at ER-mitochondria contact sites (mitochondria-associated membranes, or MAMs), allowing Ca²⁺ to flow from the ER directly into mitochondria. The resulting mitochondrial calcium overload impairs mitochondrial function and generates reactive oxygen species and other pro-senescence signals, ultimately locking tubular cells in an irreversible growth arrest.
In human kidney biopsies, Panx1 expression correlated strongly with SA-β-Gal staining (a senescence marker) and co-localized with p21 and AQP-1 in tubular epithelial cells, with levels markedly higher in aged versus young tissue. In two established murine AKI models — unilateral ischemia-reperfusion injury (uIRI) and repeated low-dose cisplatin (RLDC) — Panx1 expression was similarly elevated alongside senescence markers. Critically, genetic knockout of Panx1 in male mice substantially attenuated renal senescence, the senescence-associated secretory phenotype (SASP), and downstream fibrosis in both models.
In cultured human TECs, siRNA-mediated Panx1 knockdown reduced irradiation- and cisplatin-induced senescence, as measured by decreased SA-β-Gal staining, reduced expression of CDKN2A (p16), CDKN1A (p21), and TP53, and lower SASP cytokine levels (IL-1β, IL-6, IFN-β, TNF-β). Mechanistically, the authors demonstrated that Panx1 at ER-mitochondria contact sites drives the calcium overload cascade, implicating this subcellular compartment — not the plasma membrane — as the primary pathological site of Panx1 activity in this context.
These findings collectively identify ER-resident Panx1 as a previously unappreciated driver of the AKI-CKD transition and a potential therapeutic target for slowing kidney disease progression. The study's validation in human tissue strengthens translational relevance, though further work in female animals and clinical populations will be needed.
Key Findings
- ER-resident Panx1 acts as a Ca²⁺ leak channel at ER-mitochondria contact sites, causing mitochondrial calcium overload.
- Panx1 expression is significantly elevated in aged human and mouse kidneys and correlates with senescence markers.
- Panx1 knockout in male AKI mice markedly reduced tubular cell senescence, SASP, and kidney fibrosis.
- Panx1 knockdown in human TECs attenuated irradiation- and cisplatin-induced senescence in vitro.
- Panx1-mediated mitochondrial dysfunction generates pro-senescence signals driving the AKI-to-CKD transition.
Methodology
The study combined two murine AKI models (unilateral ischemia-reperfusion injury and repeated low-dose cisplatin) with Panx1 global knockout male mice, in vitro human TEC senescence models (irradiation and cisplatin), human kidney biopsies from young versus aged donors, and mechanistic assays including RNAscope in situ hybridization, SA-β-Gal staining, Ca²⁺ imaging, and mitochondrial function assays.
Study Limitations
The in vivo experiments were conducted exclusively in male mice, limiting conclusions about sex-specific effects. Global Panx1 knockout was used rather than tubule-specific deletion, leaving open questions about cell-type contributions. The precise structural mechanism by which Panx1 localizes to and functions at ER-mitochondria contact sites requires further characterization.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.